These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 37852632)

  • 1. Biomimetic Nanocarriers of Pro-Resolving Lipid Mediators for Resolution of Inflammation in Atherosclerosis.
    Anghelache M; Voicu G; Deleanu M; Turtoi M; Safciuc F; Anton R; Boteanu D; Fenyo IM; Manduteanu I; Simionescu M; Calin M
    Adv Healthc Mater; 2024 Jan; 13(3):e2302238. PubMed ID: 37852632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition.
    Serhan CN; Libreros S; Nshimiyimana R
    Semin Immunol; 2022 Jan; 59():101597. PubMed ID: 35227568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro-resolving lipid mediators in the resolution of neointimal hyperplasia pathogenesis in atherosclerotic diseases.
    Satish M; Agrawal DK
    Expert Rev Cardiovasc Ther; 2019 Mar; 17(3):177-184. PubMed ID: 30582389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specialized Pro-Resolving Lipid Mediators: New Therapeutic Approaches for Vascular Remodeling.
    Díaz Del Campo LS; Rodrigues-Díez R; Salaices M; Briones AM; García-Redondo AB
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specialized pro-resolving mediators in cardiovascular diseases.
    Fredman G; Spite M
    Mol Aspects Med; 2017 Dec; 58():65-71. PubMed ID: 28257820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Pharmacology of Inflammation Resolution in Atherosclerosis.
    Kotlyarov S; Kotlyarova A
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into the role of the resolvin D2-GPR18 signaling axis in cardiovascular physiology and disease.
    Spite M; Fredman G
    Adv Pharmacol; 2023; 97():257-281. PubMed ID: 37236761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of T-Cell Immune Responses by Pro-Resolving Lipid Mediators.
    Perez-Hernandez J; Chiurchiù V; Perruche S; You S
    Front Immunol; 2021; 12():768133. PubMed ID: 34868025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose pro-resolving mediators temporally reset the resolution response to microbial inflammation.
    Serhan CN; Chiang N; Nshimiyimana R
    Mol Med; 2024 Sep; 30(1):153. PubMed ID: 39294573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pro-resolution therapeutics for cardiovascular diseases.
    Heinz J; Marinello M; Fredman G
    Prostaglandins Other Lipid Mediat; 2017 Sep; 132():12-16. PubMed ID: 28450270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specialized pro-resolving mediator network: an update on production and actions.
    Chiang N; Serhan CN
    Essays Biochem; 2020 Sep; 64(3):443-462. PubMed ID: 32885825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of non-resolving inflammation in atherosclerosis.
    Kasikara C; Doran AC; Cai B; Tabas I
    J Clin Invest; 2018 Jul; 128(7):2713-2723. PubMed ID: 30108191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specialized pro-resolving lipid mediators in endodontics: a narrative review.
    Aubeux D; Peters OA; Hosseinpour S; Tessier S; Geoffroy V; Pérez F; Gaudin A
    BMC Oral Health; 2021 May; 21(1):276. PubMed ID: 34030680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators.
    Yasmeen N; Selvaraj H; Lakhawat SS; Datta M; Sharma PK; Jain A; Khanna R; Srinivasan J; Kumar V
    Biochem Pharmacol; 2023 Mar; 209():115437. PubMed ID: 36731803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPMs exert anti-inflammatory and pro-resolving effects through positive allosteric modulation of the prostaglandin EP4 receptor.
    Alnouri MW; Roquid KA; Bonnavion R; Cho H; Heering J; Kwon J; Jäger Y; Wang S; Günther S; Wettschureck N; Geisslinger G; Gurke R; Müller CE; Proschak E; Offermanns S
    Proc Natl Acad Sci U S A; 2024 Oct; 121(41):e2407130121. PubMed ID: 39365815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PCOS: A Chronic Disease That Fails to Produce Adequately Specialized Pro-Resolving Lipid Mediators (SPMs).
    Regidor PA; de la Rosa X; Müller A; Mayr M; Gonzalez Santos F; Gracia Banzo R; Rizo JM
    Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resolution of Inflammation after Skeletal Muscle Ischemia-Reperfusion Injury: A Focus on the Lipid Mediators Lipoxins, Resolvins, Protectins and Maresins.
    Barnig C; Lutzweiler G; Giannini M; Lejay A; Charles AL; Meyer A; Geny B
    Antioxidants (Basel); 2022 Jun; 11(6):. PubMed ID: 35740110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specialized Pro-Resolving Mediators as Resolution Pharmacology for the Control of Pain and Itch.
    Ji RR
    Annu Rev Pharmacol Toxicol; 2023 Jan; 63():273-293. PubMed ID: 36100219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can Inflammation-Resolution Provide Clues to Treat Patients According to Their Plaque Phenotype?
    Fredman G
    Front Pharmacol; 2019; 10():205. PubMed ID: 30899222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Use of Specialized Pro-Resolving Mediators in Biomaterial-Based Immunomodulation.
    Sousa AB; Barbosa JN
    J Funct Biomater; 2023 Apr; 14(4):. PubMed ID: 37103313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.